MSK identified a new subtype of small cell lung cancer in young non-smokers, challenging existing treatment paradigms with ...
Rahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath ...
Patients with lung cancer who have never smoked are usually diagnosed too late for curative treatment. Pam Dalrymple, ...
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...
Medpage Today on MSN14d
Year in Review: Non-Small Cell Lung CancerThe top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully ...
Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.
Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...
Yahoo Life on MSN11d
With smoking rates declining, so too are lung cancer deaths. For nonsmokers, the numbers tell a different story.We've made massive strides against the deadly disease, but rates haven't fallen for people diagnosed with the disease who've never smoked.
Danielle Hicks: Now I want to talk about progress in early-stage non-small cell lung cancer. There have been some developments in this space, particularly, specifically, in 2022 and 2023. Doctors Towe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback